| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 13,855 | 14,220 | 15,113 | 15,769 | | Cost of Revenue | 4,934 | 5,293 | 5,898 | 6,502 | | | Gross Profit |
-
| 8,927 | 9,215 | 9,266 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,967 | 9,920 | 10,861 | 9,412 | | Non Recurring | (528) | 479 | 50 | 9,685 | | Others | 20,250 | 14,400 | 9,700 | 7,083 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (15,872) | (11,396) | (16,914) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (21,767) | (15,872) | (11,396) | (16,914) | | Interest Expense | 140 | 175 | 224 | 273 | | Income Before Tax | (21,908) | (16,047) | (11,619) | (17,187) | | Income Tax Expense |
-
| 7,234 | (4,717) | (3,907) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (21,908) | (23,281) | (6,902) | (13,280) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (21,908) | (23,281) | (6,902) | (13,280) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($21,908) | ($23,281) | ($6,902) | ($13,280) |
|
0.51% Nasdaq 
Income Statement
